Arcellx: The company raised venture funding from Novo on January 17, 2017. Developer of anti-tumor therapy. The company's anti-tumor therapy is based on T cell-mediated systems that help in detecting tumors in patients.
Sector/industry:
Biotech Company / Healthcare/Biotechnology
Characteristics:
Listing
Private
Address:
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.